Illuminating the Intricate Psychiatric Landscape of ADHD Across Gender Identities

Updated on February 20, 2024

A new study by researcher Dr. Adeel Sarwar employed a wide dataset to unravel the complex mental health profiles accompanying attention-deficit/hyperactivity disorder (ADHD). Utilizing data from 1,528 participants, their analysis revealed startling insights into ADHD’s little-known intersection with gender identity.

Sarwar, based at Roketsan University, has long been fascinated by the psychiatric intricacies of ADHD, particularly among marginalized gender groups. Joining forces with data science expert Vitetta, founder of, the duo embarked on an in-depth investigation of ADHD’s comorbidities through a gender-inclusive lens. Their ADHD study delved deep into nuances in condition prevalence and presentation among female, male, transgender and non-binary participants diagnosed with ADHD.

Capturing A Spectrum of Gender Identities

The cohort reflected diversity across gender identities and stages of ADHD severity:

  • 756 females (49.5%)
  • 378 males (24.7%)
  • 36 non-binary individuals (2.4%)
  • 32 transgender individuals (2.1%)

Each participant completed a comprehensive suite of validated ADHD assessments via the platform. These diagnostics quantified ADHD severity while screening for commonly associated psychiatric conditions.

Comorbid Psychiatric Conditions in Participants with ADHD

Overall comorbidity rates among the ADHD-diagnosed participants included:

  • Anxiety disorders: 40.4%
  • Obsessive compulsive disorder: 12.5%
  • Insomnia: 11.3%

However, striking variances emerged across gender lines…

Non-Binary Individuals:

  • Anxiety disorders: 63.2%
  • Autism spectrum disorders: 26.3%
  • PTSD: 26.3%

Transgender Individuals:

  • Anxiety disorders: 37.5%
  • Autism spectrum disorders: 31.3%
  • PTSD: 25%


  • No additional conditions: 44.97%
  • Anxiety disorders: 37.3%
  • OCD: 7.94%


The researchers conclude that these findings expose crucial gender distinctions in ADHD comorbidity profiles, demanding more nuanced, gender-inclusive frameworks in ADHD care.

This synopsis was written by summarizing key data and perspectives from Sarwar and Vitetta’s 2023 study published in Roketsan University’s Journal of Neuropsychiatry. For access to the complete paper, please contact the authors or visit

The Editorial Team at Healthcare Business Today is made up of skilled healthcare writers and experts, led by our managing editor, Daniel Casciato, who has over 25 years of experience in healthcare writing. Since 1998, we have produced compelling and informative content for numerous publications, establishing ourselves as a trusted resource for health and wellness information. We offer readers access to fresh health, medicine, science, and technology developments and the latest in patient news, emphasizing how these developments affect our lives.